Nepetoideae: History
Please note this is an old version of this entry, which may differ significantly from the current revision.

Nepetoideae is the most diverse subfamily of Lamiaceae, and some species are well known for their culinary and medicinal uses. In recent years, there has been growing interest in the therapeutic properties of the species of this group regarding inflammatory illnesses.

  • inflammation
  • Lamiaceae
  • Nepetoideae
  • secondary metabolites

1. Introduction

Within the Angiosperms, the Lamiaceae is the sixth most diverse family worldwide. It is divided into 12 subfamilies, where Nepetoideae stands out due to its diversity. Based on molecular and morphological data, it is a monophyletic subfamily, with approximately 123 genera and 3685 species [1][2]. Morphologically, Nepetoideae is characterised by herbaceous, shrubby, or rarely arboreal individuals; they are generally aromatic as they contain a diversity of terpenoids and the presence of the well-known rosmarinic acid [3][4]. Many species belonging to genera of this subfamily are known for their medicinal and culinary uses as condiments, e.g., Ocimum, Origanum, Thymus, Salvia, Melissa, and Lavandula, among others [5][6][7][8]. Other genera of economic importance are Perilla and Prunella. Perilla frutescens is used as a condiment in oriental cuisine and Prunella vulgaris is outstanding for its medicinal, culinary, and ornamental uses, respectively [9][10]. On the other hand, the need for alternative and complementary therapies to treat several health problems around the world is continuous. Relevant areas looking for relevant information on these issues include agriculture and biological sciences in the fields of biochemistry, genetics, and molecular biology, as well as in the fields of pharmacology, toxicology, and pharmaceuticals. Thus, certain countries, such as India and China, have contributed almost 25% of the publications in this area [11][12]. An interesting topic is inflammation, which is a complex set of sequential tissue changes to eliminate the initial cause of cellular injury; it presents various signs, such as local redness, swelling, pain, heat, and loss of function [13][14]. In the fields of pharmacology, toxicology, and pharmaceuticals, therapies to treat inflammation are frequently mentioned, as the inflammatory process is implicated in a wide variety of physical and mental diseases that dominate current morbidity and mortality worldwide [15][16]. At the molecular level, several chemical substances are implicated in reducing or increasing inflammation. Frequently, certain cellular stimuli trigger inflammatory processes through the release of proinflammatory cytokines and chemokines (TNF, IL-1β, IL-22, IL-17, IFN-γ, among others). Cytokines can activate endothelial cells and acute phase protein synthesis and recruit immune system cells that play a crucial role in phagocytosis and pathogen destruction. Once the cells of the immune system are activated, they release cytokines and stimulate the release of prostaglandins that mediate a series of signs and symptoms of this process [17]. Finally, for the closure of the inflammatory response, cytokines, such as IL-10, IL-37, and TGF-β, can largely suppress this mechanism and return to homeostasis; if the anti-inflammatory response is not very pronounced, it can lead to vulnerability [18][19]. Currently, glucocorticoids and non-steroidal anti-inflammatory drugs are the most commonly used therapies in the clinic to treat problems related to inflammation. These drugs provide pain relief to the patient. The main mechanism of action of these drugs is the inhibition of prostaglandins and other proteins released in the inflammatory process [20].

2. Ethnobotanical Information

According to the Encyclopedic Dictionary of Traditional Mexican Medicine, inflammation is a synonym for swelling; it is caused by blows, infections, rheumatism, local pain, heat, and redness, among others. In traditional medicine, inflammation is almost always understood as a sign or symptom present in various diseases and rarely as a condition [21]. Thus, the search for literature describing traditional uses related to the inflammatory process include 33 genera and 106 species of the Nepetoideae subfamily worldwide. Regions where they are used include Chile, Brazil, Ecuador, Nicaragua, Panama, Costa Rica, Mexico, USA, and Canada in the American continent [22][23][24][25][26][27][28][29], Spain, Greece, Italy, Turkey, Algeria, Libya, Morocco, Mauritania, Tunisia, and Israel from the Mediterranean Sea, and China, India, Nepal, and Pakistan from the Himalayan region [30][31][32][33][34][35][36][37][38]. Other regions include the Philippines, Malaysia, and Thailand from Southeast Asia, and some islands, such as Monserrat, Samoa, and Madagascar [39][40][41][42][43][44].
The genera with the most reports of traditional uses for inflammation-related conditions are Mentha, Ocimum, and Salvia. The most mentioned species was Mentha longifolia (L.) Hudson, M. spicata L., Ocimum sanctum L., and Salvia rosmarinus L. M. longifolia and M. spicata are used for inflammation of the throat, gums, and eyes. O. sanctum is used in India to treat everything from constipated flu to chronic pain. Meanwhile, S. rosmarinus is used against neuritis, rheumatism, and uterine fibrosis [31][34][35][45]. The genera distributed in the American continent are Agastache, Cunila, Hedeoma, and Hyptis, all of which are used to treat various conditions, such as gastrointestinal pain and inflammation, gingivitis, blows, rheumatism, wounds, earaches, bones, and colic [21][46][47].
Elsholtzia, Isodon, and Orthosiphon are widely used in Oriental medicine for skin conditions (e.g., wounds and psoriasis), the respiratory tract (tonsillitis and pharyngitis), and colic pain, respectively [48][49][50]. Some genera are part of the culinary culture of many countries, such as Mentha, Ocimum, Origanum, and Thymus, where they are used as condiments and for gastrointestinal ailments (diarrhea, dysentery, and colic), the respiratory system (asthma, colds, catarrh, and bronchitis), to reduce fever, to reduce swelling, and for some chronic issues, such as uterine fibrosis [30][51][52][53]. A highly cited genus is Salvia, known both in Mediterranean cuisine for its culinary use and in traditional medicine in different countries including Mexico, China, and India. Salvias are used to treat wounds, pain, infections, fever, rheumatism, uterine fibrosis, and burns, among others [29][32][50]. Asterohyptis mociniana (Benth.) Epling and Isodon rubescens (Hemsl.) H. Hara are used to treat gastroenteritis, whereas Clinopodium brownei Kuntze and Plectranthus scutellarioides Blume are used for swelling. In the cases of Minthostachys mollis (Kunth) Griseb. and Monarda fistulosa L., they have been reported for bronchitis, while Calamintha acinos Man. and Lepechinia spicata Willd. have been reported for lung problems [21][22][29][33][50][54][55][56]. All of these genera produce a considerable number of secondary metabolites, which alone or in synergy have beneficial biological properties for human health, making excellent functional foods, which could subsequently be developed as nutraceuticals [57].

3. Pharmacology

In general, it is known that polar preparations are the most commonly used medicinal plants in folk medicine, and they are included in the most representative studies explored in bioassays and phytochemical studies [58]. In the case of the Nepetoideae subfamily species, preparations commonly used in folk medicine are produced through infusion or decoction of the whole plant or other independent parts. However, not only polar extractions but also non-polar extracts using different organic solvents and the essential oil have been reported to identify and isolate bioactive metabolites with anti-inflammatory activity. A total of 831 species of the Nepetoideae subfamily were obtained with at least one article indexed in any category in the Scopus database. From the 831 species, a total of 39 genera and 308 species were reported in 3124 articles, all of them associated with the anti-inflammatory activity. In this regard, the genera with the most publications (100–1400) were Salvia, Ocimum, Thymus, Mentha, Origanum, Lavandula, and Melissa. It was followed by 17 genera with 10 to 100 articles, of which 12 belong to the Menthae tribe (Prunella, Satureja, Zataria, Nepeta, Dracocephalum, Hyssopus, Agastache, Glechoma, Ziziphora, Clinopodium, Monarda, and Lycopus), 4 belong to the Ocimeae tribe (Isodon, Orthosiphon, Plectrathus, and Hyptis), and only 1 is from the Elsholtziae tribe (Elsholtzia).
Within the genus Salvia, there are approximately 111 species reported in relation to the inflammatory process. The most studied species are S. miltiorrhiza Bunge and S. officinalis L.. For S. miltiorrhiza, its properties have been reported using the root extracts, where a number of isolated diterpenes called tanshinones were also identified as responsible for the effect on the reduction of proinflammatory cytokines in in vitro assays [59]. The reduction of fibrosis in the liver, heart, lung, and kidney was reported in in vivo models, with improvement against allergies, asthma, and rhinitis using clinical tests [60][61]. Anti-inflammatory effects of S. officinalis have been described in in vivo tests prepared as organic extracts of different polarity and aqueous extracts, in which the main component was rosmarinic acid [62]. S. dolomitica Codd, S. frigida L., S. nipponica Miq., S. petrophilla G. X. Hu, E. D. Liu, and Yan Liu, S. plebeia R. Br., and S. sclareoides Brot. reduced the enzymatic activity of elastase and inflammatory mediator molecules, such as nitric oxide (NO), IL-4, IL-13, IL-5, TNF-α, cyclooxygenase (COX)-2, and prostaglandine PGE2 in RAW 264.7 macrophages induced with LPS in organic extracts of different polarities and aqueous extracts [63][64][65][66][67][68]. The polar extracts of S. chudei Batt. and Trab., S. fruticosa Mill., S. leriifolia Benth., S. macilenta Boiss., S. sclarea L., S. transsylvanica (Schur ex Griseb. and Schenk) Schur, and S. virgata Ortega demonstrated anti-inflammatory activity in the carrageenan-induced edema model in rats at a dose range of 250–1500 mg/kg. Finally, the acetone extract and the methanol extract of S. aegyptiaca L. and S. moorcroftiana Wall. ex Benth., respectively, showed antipyretic effects in murine models of hyperthermia [69][70][71][72][73][74][75][76]. After the genus Salvia, the species Ocimum tenuiflorum L. (syn. Ocimum sanctum L.), Thymus vulgaris L., Mentha spicata L., and Origanum vulgare L. are the most studied of their respective genera. The organic and aqueous extracts of O. tenuiflorum showed positive effects on the epithelialization and a reduction in the induced edema in murine models. Likewise, phenolic compounds isolated from this species, including rosmarinic acid, decreased the concentration of COX-1 in in vitro models [77][78]. The aerial part of T. vulgaris increased the activity of antioxidant enzymes in models of renal and hepatic dysfunction in rabbits, and it also had an effect against cholestasis, chronic hepatitis, and liver fibrosis in clinic studies [79]. Both the organic and aqueous extracts of M. spicata decreased edema, granulomas, and mucositis induced in murine models [80]. The essential oil of O. vulgare produced significant effects on the proinflammatory cytokines and chemokines [81]. Lavandula angustifolia Mill. and Melissa officinalis L. have been also explored for their anti-inflammatory effects. Regarding the genus Lavandula, several species have been evaluated, expect for Melissa, where only M. officinalis has been described. With respect to L. angustifolia, both the essential oil and the polyphenolic fraction reduced the levels of proinflammatory cytokines in murine models of induced edema, ischemia, chronic inflammatory pain, and sepsis [82][83][84][85][86][87][88][89]. In the case of Prunella, only P. vulgaris L. has been evaluated in this affection. The essential oil, polar extracts, as well as the isolated compounds from the inflorescences, such as the diterpene prunela diterpenol A and the phenolic compounds prunelanate A and prunelanate B, presented activity in the regulation of proinflammatory cytokines in in vitro tests [90][91][92][93]. Triterpenes, such as 2α,3α,23-trihydroxyursa-12,20(30)-dien-28-oic acid, β-amyrin, and eusapic acid, produced effects on histamine suppression in in vitro studies [94]. For the genera Satureja, Zataria, Nepeta, Glechoma, and Lycopus, few species have been studied in murine models using polar extracts of Satureja montana L. and Nepeta dschuparensis Bornm, which decreased IL-1β levels in the model of traumatic brain injury and artery occlusion infarction, respectively. Glechoma longituba (Nakai) Kuprian attenuated proinflammatory gene expression in retinas exposed to bright light, Lycopus lucidus Turcz. ex Benth. inhibited histamine release in allergy models, and Zataria multiflora Boiss. improved levels of proinflammatory cytokines in asthma models [95][96][97][98][99]. From Agastache mexicana (Kunth) Lint and Epling and Dracocephalum moldavica L., which also belong to the Mentheae tribe, the glycosylated flavonoid tilianin has been isolated, where a reduction in the mRNA expression of proinflammatory cytokines was observed in in vivo and in vitro models [100][101]. Likewise, some little-known diterpenes have been isolated from D. moldavica, such as dracocephalumoids A-E, uncinatone, trichotomone F, and caryopterisoid C, which suppressed TNF-α, IL-1β, and NO in RAW 264.7 macrophages induced with LPS [102]. Finally, the aqueous extracts of Hyssopus officinalis L. and Ziziphora clinopodioides Lam. were used for the synthesis of Zn and Fe nanoparticles, demonstrating their anti-inflammatory effect in murine models of carrageenan-induced edema and hemolytic anemia, respectively [103][104]. Diterpenoid-type compounds isolated from the aqueous extracts of species of the Ocimeae tribe have presented anti-inflammatory activity in both in vitro and in vivo models, such as the case of orthosiphol A and B obtained from Orthosiphon stamineus Benth., parvifloron D from Plectranthus ecklonii Benth., as well as suaveolol and methyl suveolate from Hyptis suaveolens (L.) Poit. [105][106][107]. Regarding the genus Isodon, such as I. adenanthus (Diels) Kudô, I. enanderianus (Hand.-Mazz.) H.W. Li, I. eriocalyx (Dunn) Kudô, I. henryi (Hemsl.) Kudô, I. leucophyllus (Dunn) Kudô, I. rugosiformis (Hand.-Mazz.) H. Hara, I. scoparius C.Y. Wu and H.W. Li) H. Hara, and I. rubescens (Hemsl.) H. Hara, a significant amount of kaurane-type diterpenes have been isolated as responsible for the activity on proinflammatory cytokines both in RAW 264.7 macrophages induced with LPS as well as in a variety of models, such as in murine infections of encephalomyelitis, prostatitis, peritonitis, gouty arthritis, and type II diabetes [108][109][110][111][112][113][114]. In the case of I. ternifolius (D.Don) Kudô, the lignans ternifoliuslignans A, B, C, D, and E and the glycosylated phenylethanoid 3-carboxy-6,7-dihydroxy-1-(3′,4′-dihydroxyphenyl)-naphthalene were characterized to suppress activity of PGE2 and TNF-α in macrophages induced with LPS [115]. I. eriocalyx, from which endophytic fungus Phomopsis sp. was first isolated, allowed the isolation of the phomopchalasins A, B, and C with NO inhibitory activity in in vitro assays [116]. Species with few studies reported in the literature were Cedronella canariensis (L.) Webb and Berthel., Hoslundia opposita Vahl, and Micromeria biflora (Buch. Ham. ex D.Don) Benth., prepared as chloroform extracts of flowers, root, and aerial part, respectively, which demonstrated anti-inflammatory effects in the murine model of edema induced with carrageenan [117][118][119]. Polar extracts of Asterohyptis stellulata (Benth.) Epling promoted skin regeneration in CD-1 mice. Micromeria croatica (Pers.) reduced the expression of proinflammatory cytokines in models of liver injury, and Mosla chinensis Maxim. and M. scabra attenuated levels of inflammatory mediators in models of ulcerative colitis [120][121][122][123]. From the petroleum ether extracts of Horminum pyrenaicum L., abietane-type diterpenes were isolated that suppressed the activity in immunometabolic pathways related to inflammatory processes in murine models [124]. All of this information together demonstrates that different classes of natural compounds are investigated for their anti-inflammatory potential properties in the species of the Nepetoideae subfamily. The chemical structure diversity found in natural products has served as an attractive approach in searching for relevant anti-inflammatory drugs, as it can be possible from this subfamily. Thus, the chemical structure diversity is not a factor in producing similar biological activity; however, the bioactivity can be improved by modifying the structure [125][126]. Due to this, it is important to notice that natural chemical compounds show a wide spectrum of activities and interaction in several molecular targets responsible for the anti-inflammatory activity of these species because it can be more than one at the same time. As an example, several compounds possessing antioxidant properties can prevent and/or reduce oxidative stress, which is relevant in inflammation and neurodegenerative diseases. The activity–structure relationship of several common polyphenols in plants, such as gallic acid reported in some species of the Nepetoideae subfamily, have demonstrated that the higher the number of phenolic hydroxyl groups, the stronger the antioxidant activity that regulates inflammatory mechanisms and pathways [126]. The interaction of some flavonoids in several targets at the same time, such as quercetin derivatives, has been reported using antagonists of inhibitory receptors, such as endogenous opioids, and those of serotoninergic and/or dopaminergic neurotransmission involved in neurodegenerative diseases have been explored by using predictive molecular docking, too, in order to support their important role at peripheral and central levels [125]. Some natural products from a terpenoid nature, such as sclareol, which are also found in species of this subfamily, produced their anti-inflammatory activity by inhibiting not only NO production but also the expression of iNOS and COX-2 proteins, as well as in the MAPK signaling pathway [61]. Meanwhile, tanshinone II activity has been supported by regulating the CCNA2-CDK2 complex and AURKA/PLK1 pathways [127]. Further structure activity relationship studies are encouraged for metabolites found in the Nepetoideae subfamily species, as in other plants, to identify not only the chemical compounds but also their mechanisms of action involved in their potential biological activities as anti-inflammatory therapy to improve health.

4. Phytochemistry

Chemical secondary metabolites have been identified and isolated using dissolvents of different polarity through several techniques of extraction [128]. Therefore, phytochemical techniques have allowed for the determination of the main components of some species of the subfamily Nepetoideae. This section generally describes some of the compounds commonly identified in the subfamily (mono- and tri-terpenoids, phenolic acids, and flavonoids). It also mentions the case of clerodane and kaurano-type diterpenes, which have different biological activities and have only been isolated in certain genera, such as Salvia and Isodon. Monoterpenes have been the most identified, such as thymol (C1) and carvacrol (C2), which are important components of the essential oils of Collinsonia, Monarda, Ocimum, Origanum, Satureja, Thymbra, Thymus, and Zataria [81][95][129][130][131][132][133][134]. On the contrary, there are exclusive molecules of certain genera, as exemplified by Mentha, where menthol (C3), menthone (C4), and eucalyptol (C5) predominate. In the case of Lavandula and Melissa, linalool and nerol have been identified as the most important constituents, respectively [135][136][137]. Different phenolic acids have been reported throughout the subfamily, such as caffeic acid, ferulic acid, gallic acid, chlorogenic acid, sinapic acid, and a high presence of rosmarinic acid (C6) [138][139][140][141][142][143]. Similarly, the presence of flavonoids and their glycosylated derivatives, such as quercetin, luteolin, and naringenin, have been very common [120][132][134][136][137]. In contrast, the presence of the flavonoid tilianin (C7) has been reported only in Agastache and Dracocephalum [98][99]. It is important to notice that diterpenes are the chemical group less explored throughout the subfamily. The species of Dracocephalum taliense Forrest and Horminum pyrenaicum L. included the abietanes sugiol, ferruginol, cryptojaponol, and totarol isolated from roots. Dracocephalumoids A, B, C, and D (C8–C11), and orthosiphol A and B (C12–C13) were purified from Dracocephalum moldavica L. and Orthosiphon stamineus Benth. [102][105][144]. Other genera, such as Salvia and Isodon, stand out for the great diversity of diterpenes that have been isolated and identified in several of their species. In the case of Salvia, terpenes of abietane, clerodane, labdane, and pimarane-type structures have been described. Some examples are tanshinone IIA (C14) and sclareol (C15) isolated from S. miltiorrhiza and S. sclarea, respectively [59][60][61][62][63][64][65][66][67][68][69]. In the case of the genus Isodon, compounds with a Kaurano-type skeleton predominated, and some common cases among the species were adenanthine (C16), eriocalyxin B (C17), and oridonine (C18) [108][111][145].

This entry is adapted from the peer-reviewed paper 10.3390/plants12213752

References

  1. Gul, S.; Ahmad, M.; Zafar, M.; Bahadur, S.; Sultana, S.; Begum, N.; Shah, S.N.; Zaman, W.; Ullah, F.; Ayaz, A.; et al. Taxonomic study of subfamily Nepetoideae (Lamiaceae) by polynomorphological approach. Microsc. Res. Tech. 2019, 82, 1021–1031.
  2. da Silva-Monteiro, F.K.; de Melo, J.I.M. Flora of Paraíba, Brazil: Subfamily Nepetoideae (Lamiaceae). Rodriguesia 2020, 71, 1–22.
  3. Harley, R.M.S.; Atkins, A.L.; Budantsev, P.D.; Cantino, B.J.; Conn, R.; Grayer, M.M.; Harley, R.; De Kok, T.; Krestovskaja, R.; Morales, A.J.; et al. Labiatae. In Labiatae. The Families and Genera of Vascular Plants VII. Flowering Plants Dicotyledons: Lamiales (Except Acanthaceae including Avicenniaceae); Kubitzki, J.K.Y., Kadereit, W., Eds.; Springer: Berlin/Heidelberg, Germany, 2004; pp. 167–275.
  4. Omar, S.H. Biophenols: Impacts and prospects in anti-Alzheimer drug discovery. In Discovery and Development of Neuroprotective Agents from Natural Products; Brahmachari, G., Ed.; Elsevier: Amsterdam, The Netherlands, 2018; pp. 103–148.
  5. Burk, L.; O’Brien, B.; Charron, J.M.; Sherman, K.J.; Bullock, M.L. Psychic/intuitive diagnosis: Two case reports and commentary; experiences with aromatherapy in the elderly; use of Lavandula latifolia as an expectorant; characteristics and complaints of patients seeking therapy. J. Altern. Complement. Med. 1997, 3, 209–212.
  6. Bornowski, N.; Hamilton, J.P.; Liao, P.; Wood, J.C.; Dudareva, N.; Buell, C.R. Genome sequencing of four culinary herbs reveals terpenoid genes underlying chemodiversity in the Nepetoideae. DNA Res. 2020, 27, 1–12.
  7. El Yaagoubi, M.; Mechqoq, H.; el Hamdaoui, A.; Jrv Mukku, V.; el Mousadik, A.; Msanda, F.; el Aouad, N. A review on Moroccan Thymus species: Traditional uses, essential oils chemical composition and biological effects. J. Ethnopharmacol. 2021, 278, 114205.
  8. Draginic, N.; Jakovljevic, V.; Andjic, M.; Jeremic, J.; Srejovic, I.; Rankovic, M.; Tomovic, M.; Nikolic Turnic, T.; Svistunov, A.; Bolevich, S.; et al. Melissa officinalis L. as a nutritional strategy for cardioprotection. Front. Physiol. 2021, 12, 1778.
  9. Li, P.; Qi, Z.C.; Liu, L.X.; Ohi-Toma, T.; Lee, J.; Hsieh, T.H.; Fu, C.X.; Cameron, K.M.; Qiu, Y.X. Molecular phylogenetics and biogeography of the mint tribe Elsholtzieae (Nepetoideae, Lamiaceae), with an emphasis on its diversification in East Asia. Sci. Rep. 2017, 7, 2057.
  10. Pan, J.; Wang, H.; Chen, Y. Prunella vulgaris L.—A review of its ethnopharmacology, phytochemistry, quality control and pharmacological effects. Front. Pharmacol. 2022, 13, 3171.
  11. Elsevier, B.V. Analyze Search Results: Lamiaceae 1980–2023. Available online: www.scopus.com (accessed on 15 January 2023).
  12. Youn, B.Y.; Moon, S.; Mok, K.; Cheon, C.; Ko, Y.; Park, S.; Jang, B.H.; Shin, Y.C.; Ko, S.G. Use of traditional, complementary and alternative medicine in nine countries: A cross-sectional multinational survey. Complement. Ther. Med. 2022, 71, 102889.
  13. Liu, C.H.; Abrams, N.D.; Carrick, D.M.; Chander, P.; Dwyer, J.; Hamlet, M.R.J.; Macchiarini, F.; Prabhudas, M.; Shen, G.L.; Tandon, P.; et al. Biomarkers of chronic inflammation in disease development and prevention: Challenges and opportunities. Nat. Immunol. 2017, 18, 1175–1180.
  14. What Is an Inflammation? Institute for Quality and Efficiency in Health Care (IQWiG): Cologne, Germany, 2006. Available online: www.ncbi.nlm.nih.gov/books/NBK279298 (accessed on 12 December 2022).
  15. Slavich, G.M. Understanding inflammation, its regulation, and relevance for health: A top scientific and public priority. Brain Behav. Immun. 2015, 45, 13–14.
  16. Bennett, J.M.; Reeves, G.; Billman, G.E.; Sturmberg, J.P. Inflammation-nature’s way to efficiently respond to all types of challenges: Implications for understanding and managing “the epidemic” of chronic diseases. Front. Med. 2018, 5, 316.
  17. Netea, M.G.; Balkwill, F.; Chonchol, M.; Cominelli, F.; Donath, M.Y.; Giamarellos-Bourboulis, E.J.; Golenbock, D.; Gresnigt, M.S.; Heneka, M.T.; Hoffman, H.M.; et al. A guiding map for inflammation. Nat. Immunol. 2017, 18, 826–831.
  18. Ouyang, W.; Rutz, S.; Crellin, N.K.; Valdez, P.A.; Hymowitz, S.G. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu. Rev. Immunol. 2011, 29, 71–109.
  19. Dinarello, C.A.; Nold-Petry, C.; Nold, M.; Fujita, M.; Li, S.; Kim, S.; Bufler, P. Suppression of innate inflammation and immunity by interleukin-37. Eur. J. Immunol. 2016, 46, 1067–1081.
  20. Nunes, C.d.R.; Barreto Arantes, M.; Menezes de Faria Pereira, S.; Leandro da Cruz, L.; de Souza Passos, M.; Pereira de Moraes, L.; Vieira, I.J.C.; Barros de Oliveira, D. Plants as sources of anti-inflammatory agents. Molecules 2020, 25, 3726.
  21. Argueta, A.; Cano, L.; Rodarte, M.; Gallardo, C. Atlas de las Plantas de la Medicina Tradicional Mexicana; Instituto Nacional Indigenista: Mexico City, Mexico, 1994; 1786p.
  22. Core, E.L. Ethnobotany of the southern Appalachian aborigines. Econ. Bot. 1966, 21, 198–214.
  23. Turner, N.; Bell, M. The ethnobotany of the coast Salish Indians of Vancouver island. Econ. Bot. 1971, 25, 63–99.
  24. Aldunate, C.; Armesto, J.J.; Castro, V.; Villagran, C. Ethnobotany of pre-altiplanic community in the Andes of Northern Chile. Econ. Bot. 1983, 37, 120–135.
  25. Hazlett, D.L. Ethnobotanical observations from Cabecar and Guaymi settlements in Central America. Econ. Bot. 1986, 40, 339–352.
  26. Bye, R.A. Medicinal plants of the Sierra Madre: Comparative study of Tarahumara and Mexican market plants. Econ. Bot. 1986, 40, 103–124.
  27. Barret, B. Medicinal plants of Nicaragua’s Atlantic coast. Econ. Bot. 1994, 48, 8–20.
  28. Voeks, R.A. Tropical forest healers and habitat preference. Econ. Bot. 1996, 50, 381–400.
  29. Rios, M.; Koziol, M.; Borgtoft, H.; Granda, G. Plantas Útiles del Ecuador; Abya-Yala: Quito, Ecuador, 2007; p. 652.
  30. Fujita, T.; Sezik, E.; Tabata, M.; Yesilada, G.; Takeda, Y.; Tanaka, T.; Takaishi, Y. Traditional medicine in Turkey VII. Folk medicine in middle and west black sea regions. Econ. Bot. 1995, 49, 406–422.
  31. Martínez-Lirola, M.J.; Gonzalez-Tejero, M.R.; Molero-Mesa, J. Ethnobotanical resources in the province of Almería, Spain: Campos de Nijar. Econ. Bot. 1996, 50, 40–56.
  32. Rivera, D.; Obón, C.; Cano, F. The botany, history and traditional uses of three-lobed sage (Salvia fruticosa Miller) (Labiatae). Econ. Bot. 1994, 48, 190–195.
  33. Brussell, D. A medicinal plant collection from Montserrat, west indies. Econ. Bot. 2004, 58, s203–s220.
  34. Dagar, H.S.; Dagar, J.C. Plant folk medicines among the Nicobarese of Katchal Island, India. Econ. Bot. 1990, 45, 114–119.
  35. Bhattarai, N.K. Medical ethnobotany in the Karnali zone, Nepal. Econ. Bot. 1992, 46, 257–261.
  36. Huai, H.Y.; Pei, S.J. Plants used medicinally by folk healers of the Lahu people from the autonomous county of Jinping Miao, Yao, and Dai in southwest China. Econ. Bot. 2004, 58, 265s–273s.
  37. Ajaib, M.; Ishtiaq, M.; Bhatti, K.H.; Hussain, I.; Maqbool, M.; Hussain, T.; Mushtaq, W.; Ghani, A.; Azeem, M.; Khan, S.M.R.; et al. Inventorization of traditional ethnobotanical uses of wild plants of Dawarian and Ratti Gali areas of District Neelum, Azad Jammu and Kashmir Pakistan. PLoS ONE 2021, 16, e0255010.
  38. Lahlou, R.A.; Samba, N.; Soeiro, P.; Alves, G.; Gonçalves, A.C.; Silva, L.R.; Silvestre, S.; Rodilla, J.; Ismael, M.I. Thymus hirtus Willd. ssp. algeriensis Boiss. and Reut: A Comprehensive Review on Phytochemistry, Bioactivities, and Health-Enhancing Effects. Foods 2022, 11, 3195.
  39. Anderson, E.F. Ethnobotany of hill tribes of northern Thailand. I. Medicinal plants of Akha, I. Econ. Bot. 1986, 40, 38–53.
  40. Cox Bodner, C.; Gereau, R.E. A contribution to Bontoc ethnobotany. Econ. Bot. 1988, 42, 307–369.
  41. Christensen, H. Ethnobotany of the Iban & the Kelabit; Oko-Tryk Press: Copenhagen, Denmark, 2002; 384p.
  42. Uhe, G. Medicinal plants of Samoa a preliminary survey of the use of plants for medicinal purposes in the Samoan Islands. Econ. Bot. 1974, 28, 1–30.
  43. Quansah, N. Ethnomedicine in the Maroantsetra region of Madagascar. Econ. Bot. 1988, 42, 370–375.
  44. Brussell, D. Medicinal plants of Mt. Pelion, Greece. Econ. Bot. 2004, 58, 176s–202s.
  45. Weckerle, C.; Huber, F.; Yongping, Y.; Weibang, S. Plant knowledge of the Shuhi in the Hengduan mountains, southwest China. Econ. Bot. 2006, 60, 3–23.
  46. Gispert Cruells, M.; Rodríguez González, H. Los Coras: Plantas Alimentarias y Medicinales de su Ambiente Natural; CONACULTA Culturas Populares: Mexico City, Mexico, 1988; 128p.
  47. Monroy-Ortiz, C.; Monroy, R. Las plantas, Compañeras De Siempre: La Experiencia En Morelos; Universidad Autónoma del Estado de Morelos: Cuernavaca, Mexico, 2006; 184p, ISBN 9701816145.
  48. Manandhar, N.P. Medicinal plant-lore of Tamang tribe of Kabhrepalanchok district, Nepal. Econ. Bot. 1991, 45, 58–71.
  49. Pal, D.C.; Jain, S.K. Notes on Lodha medicine in Midnapur district, West Bengal, India. Econ. Bot. 1989, 43, 464–470.
  50. Chen, X.; Dai, X.; Liu, Y.; He, X.; Gong, G. Isodon rubescens (Hemsl.) Hara.; A comprehensive review in traditional uses, phytochemistry, and pharmacological activities. Front. Pharmacol. 2022, 13, 766581.
  51. Balick, M.J.; Kronenberg, F.; Ososki, A.L.; Fugh-Berman, A.; Roble, M.; Lohr, P.; Atha Balick, D.; Reiff, M. Medicinal plants used by Latino healers for women’s health conditions in New York city. Econ. Bot. 2000, 54, 344–357.
  52. Dolores, B.M.; Croce, H.M.; Cerda, L.M. Plantas Útiles de la Región Semiárida de Aguascalientes; Universidad Autónoma de Aguascalientes: Aguascalientes, Aguascalientes, 2003.
  53. Pérez-Nicolás, M.; Vibrans, H.; Romero-Manzanares, A.; Saynes-Vásquez, A.; Luna-Cavazos, M.; Flores-Cruz, M.; Lira-Saade, R. Patterns of Knowledge and Use of Medicinal Plants in Santiago Camotlán, Oaxaca, México. Econ. Bot. 2017, 71, 209–223.
  54. Breedlove, D.; Laughlin, R. The Flowering of Man: A Tzotzil Botany of Zinacantán, Volume I; Smithsonian Contributions to Anthropology, Number 35; Smithsonian Institution Press: Washington, DC, USA, 1993.
  55. Isidro, V.M. Etnobotánica de los Zoques de Tuxtla Gutiérrez, Chiapas; Instituto de Historia Natural: Chiapas, México, 1997; p. 59.
  56. De La Cruz-Jiménez, L.; Guzmán-Lucio, M.; Viveros-Valdez, E. Traditional medicinal plants used for the treatment of gastrointestinal diseases in Chiapas, México. World Appl. Sci. J. 2014, 31, 508–515.
  57. Carović-Stanko, K.; Petek, M.; Grdiša, M.; Pintar, J.; Bedeković, D.; Herak, M. Medicinal plants of the family Lamiaceae as functional foods—A Review. J. Food Sci. 2016, 5, 377–390.
  58. Abubakar, A.R.; Haque, M. Preparation of medicinal plants: Basic extraction and fractionation procedures for experimental purposes. J. Pharm. Bioallied Sci. 2020, 12, 1–10.
  59. Feng, J.; Liu, L.; Yao, F.; Zhou, D.; He, Y.; Wang, J. The protective effect of tanshinone IIA on endothelial cells: A generalist among clinical therapeutics. Expert. Rev. Clin. Pharmacol. 2021, 14, 239–248.
  60. Mahalakshmi, B.; Huang, C.Y.; da Lee, S.; Maurya, N.; Kiefer, R.; Bharath Kumar, V. Review of Danshen: From its metabolism to possible mechanisms of its biological activities. J. Funct. Foods 2021, 85, 104613.
  61. Yang, N.; Zou, C.; Luo, W.; Xu, D.; Wang, M.; Wang, Y.; Wu, G.; Shan, P.; Liang, G. Sclareol attenuates angiotensin II -induced cardiac remodeling and inflammation via inhibiting MAPK signaling. Phytother. Res. 2022, 37, 578–591.
  62. Miraj, S.; Kiani, S. A review study of therapeutic effects of Salvia officinalis L. Pharm. Lett. 2016, 8, 299–303. Available online: www.researchgate.net/publication/305147951 (accessed on 20 January 2023).
  63. Kamatou, G.P.P.; Van Zyl, R.L.; Van Vuuren, S.F.; Viljoen, A.M.; Figueiredo, A.C.; Barroso, J.G.; Tilney, P.M. Chemical composition, leaf trichome types and biological activities of the essential oils of four related Salvia species indigenous to southern Africa. J. Essent. Oil Res. 2006, 18, 72–79.
  64. Chan, H.H.; Hwang, T.L.; Su, C.R.; Reddy, M.V.B.; Wu, T.S. Anti-inflammatory, anticholinesterase and antioxidative constituents from the roots and the leaves of Salvia nipponica Miq. var. formosana. Phytomedicine 2011, 18, 148–150.
  65. Jang, H.H.; Cho, S.Y.; Kim, M.J.; Kim, J.B.; Lee, S.H.; Lee, M.Y.; Lee, Y.M. Anti-inflammatory effects of Salvia plebeia R. Br. extract in vitro and in an ovalbumin-induced mouse model. Biol. Res. 2016, 49, 41.
  66. Batista, D.; Falé, P.L.; Serralheiro, M.L.; Araújo, M.E.; Dias, C.; Branco, I.; Grosso, C.; Coelho, J.; Palavra, A.; Madeira, P.J.A.; et al. Phytochemical characterization and biological evaluation of the aqueous and supercritical fluid extracts from Salvia sclareoides Brot. Open Chem. 2017, 15, 82–91.
  67. Hassan, Z.Y.; Hassan, T.Y.; Abu-Raghif, A.R. Evaluation the Effectiveness of Phenolic Compound of Salvia frigida on Induced Atopic Dermatitis in Experimental Mice. Iraqi J. Pharm. Sci. 2022, 31, 154–166.
  68. Zou, Z.Q.; Ning, D.S.; Liu, Y.; Fu, Y.X.; Li, L.C.; Pan, Z.H. Five new germacrane sesquiterpenes with anti-inflammatory activity from Salvia petrophila. Phytochem. Lett. 2022, 47, 111–114.
  69. Moretti, M.D.L.; Peana, A.T.; Satta, M. A study on anti-inflammatory and peripheral analgesic action of Salvia sclarea oil and its main components. J. Essent. Oil Res. 1997, 9, 199–204.
  70. Hosseinzadeh, H.; Yavary, M. Anti-inflammatory effect of Salvia leriifolia Benth. leaf extract in mice and rats. Pharm. Pharmacol. Lett. 1999, 9, 60–61.
  71. Maklad, Y.A.; Aboutabl, E.A.; El-Sherei, M.M.; Meselhy, K.M. Bioactivity studies of Salvia transsylvanica (Schur. ex Griseb.) grown in Egypt. Phytother. Res. 1999, 13, 147–150.
  72. Al-Yousuf, M.H.; Bashir, A.K.; Ali, B.H.; Tanira, M.O.M.; Blunden, G. Some effects of Salvia aegyptiaca L. on the central nervous system in mice. J. Ethnopharmacol. 2002, 81, 121–127.
  73. Boukhary, R.; Raafat, K.; Ghoneim, A.I.; Aboul-Ela, M.; El-Lakany, A. Anti-inflammatory and antioxidant activities of Salvia fruticosa: An HPLC determination of phenolic contents. Evid.-Based Complement. Altern. Med. 2016, 2016, 7178105.
  74. Hussain, L.; Sajid Hamid Akash, M.; Imran Qadir, M.; Pharm Sci, P.J.; Iqbal, R.; Irfan, M.; Imran Qadir, M. Analgesic, anti-inflammatory, and antipyretic activity of Salvia moorcroftiana. Pak. J. Pharm. Sci. 2017, 30, 7134. Available online: https://www.researchgate.net/publication/316007134_Analgesic_anti-inflammatory_and_antipyretic_activity_of_Salvia_moorcroftiana (accessed on 25 June 2023).
  75. Semaoui, R.; Ouafi, S.; Machado, S.; Barros, L.; Ferreira, I.C.F.R.; Oliveira, M.B.P.P. Infusion of aerial parts of Salvia chudaei Batt. & Trab. from Algeria: Chemical, toxicological and bioactivities characterization. J. Ethnopharmacol. 2021, 280, 114455.
  76. Taheri, S.; Khalifeh, S.; Shajiee, H.; Ashabi, G. Dietary uptake of Salvia macilenta extract improves Nrf2 antioxidant signaling pathway and diminishes inflammation and apoptosis in amyloid beta-induced rats. Mol. Biol. Rep. 2021, 48, 7667–7676.
  77. Pattanayak, P.; Behera, P.; Das, D.; Panda, S. Ocimum sanctum L. A reservoir plant for therapeutic applications: An overview. Pharmacogn. Rev. 2010, 4, 95–105.
  78. Singh, D.; Chaudhuri, P.K. A review on phytochemical and pharmacological properties of Holy basil (Ocimum sanctum L.). Ind. Crops Prod. 2018, 118, 367–382.
  79. Bacalbasa, N.; Balescu, I.; Stoica, C.; Pop, L.; Varlas, V.; Martac, C.; Voichitoiu, A.; Gaspar, B. The anti-inflammatory, anti-infectious and anti-cancerous effects of Thymus vulgaris. Rom. Med. J. 2022, 17, 21–23.
  80. el Menyiy, N.; Mrabti, H.N.; el Omari, N.; Bakili, A.E.; Bakrim, S.; Mekkaoui, M.; Balahbib, A.; Amiri-Ardekani, E.; Ullah, R.; Alqahtani, A.S.; et al. Medicinal Uses, Phytochemistry, Pharmacology, and Toxicology of Mentha spicata. Evid.-Based Complement. Altern. Med. 2022, 2022, 7990508.
  81. Sharifi-Rad, M.; Berkay Yılmaz, Y.; Antika, G.; Salehi, B.; Tumer, T.B.; Kulandaisamy Venil, C.; Das, G.; Patra, J.K.; Karazhan, N.; Akram, M.; et al. Phytochemical constituents, biological activities, and health-promoting effects of the genus Origanum. Phytother. Res. 2021, 35, 95–121.
  82. Hajhashemi, V.; Ghannadi, A.; Sharif, B. Anti-inflammatory and analgesic properties of the leaf extracts and essential oil of Lavandula angustifolia Mill. J. Ethnopharmacol. 2003, 89, 67–71.
  83. Zhao, J.; Xu, F.; Huang, H.; Ji, T.; Li, C.; Tan, W.; Chen, Y.; Ma, L. Evaluation on bioactivities of total flavonoids from Lavandula angustifolia. Pak. J. Pharm. Sci. 2015, 28, 1245–1251.
  84. Giovannini, D.; Gismondi, A.; Basso, A.; Canuti, L.; Braglia, R.; Canini, A.; Mariani, F.; Cappelli, G. Lavandula angustifolia mill. Essential oil exerts antibacterial and anti-inflammatory effects in macrophage mediated immune response to staphylococcus aureus. Immunol. Investig. 2016, 45, 11–28.
  85. Georgiev, Y.N.; Paulsen, B.S.; Kiyohara, H.; Ciz, M.; Ognyanov, M.H.; Vasicek, O.; Rise, F.; Denev, P.N.; Yamada, H.; Lojek, A.; et al. The common lavender (Lavandula angustifolia Mill.) pectic polysaccharides modulate phagocytic leukocytes and intestinal Peyer’s patch cells. Carbohydr. Polym. 2017, 174, 948–959.
  86. Cardia, G.F.E.; Silva-Filho, S.E.; Silva, E.L.; Uchida, N.S.; Cavalcante, H.A.O.; Cassarotti, L.L.; Salvadego, V.E.C.; Spironello, R.A.; Bersani-Amado, C.A.; Cuman, R.K.N. Effect of lavender (Lavandula angustifolia) essential oil on acute inflammatory response. Evid. Based Complementary Altern. Med. 2018, 2018, 1413940.
  87. Souri, F.; Rakhshan, K.; Erfani, S.; Azizi, Y.; Maleki, S.; Aboutaleb, N. Natural lavender oil (Lavandula angustifolia) exerts cardioprotective effects against myocardial infarction by targeting inflammation and oxidative stress. Inflammopharmacology 2019, 27, 799–807.
  88. Chen, X.; Zhang, L.; Qian, C.; Du, Z.; Xu, P.; Xiang, Z. Chemical compositions of essential oil extracted from Lavandula angustifolia and its prevention of TPA-induced inflammation. Microchem. J. 2020, 153, 104458.
  89. Xie, Q.; Wang, Y.; Zou, G.L. Protective effects of lavender oil on sepsis-induced acute lung injury via regulation of the NF-κB pathway. Pharm. Biol. 2022, 60, 968–978.
  90. Hwang, Y.J.; Lee, E.J.; Kim, H.R.; Hwang, K.A. NF-κB-targeted anti-inflammatory activity of Prunella vulgaris var. lilacina in macrophages RAW 264.7. Int. J. Mol. Sci. 2013, 14, 21489–21503.
  91. Ryu, S.Y.; Oak, M.-H.; Yoon, S.-K.; Cho, D.-I.; Yoo, G.-S.; Kim, T.-S.; Kim, K.-M.; Thieme, G.; Stuttgart, V.; York, N. Anti-allergic and anti-inflammatory triterpenes from the herb of Prunella vulgaris. Planta Med. 2000, 66, 358.
  92. Tang, Y.Q.N.; Deng, J.; Li, L.; Yan, J.; Lin, L.M.; Li, Y.M.; Lin, Y.; Xia, B.H. Essential oil from Prunella vulgaris L. as a valuable source of bioactive constituents: In vitro anti-bacterial, anti-viral, immunoregulatory, anti-inflammatory, and chemical profiles. S. Afr. J. Bot. 2022, 151, 614–627.
  93. Zheng, X.Q.; Song, L.X.; Qiu, H.; Yang, Y.B.; Han, Z.Z.; Wang, Z.T.; Gu, L.H. Novel phenolic and diterpenoid compounds isolated from the fruit spikes of Prunella vulgaris L. and their anti-inflammatory activities. Phytochem. Lett. 2022, 49, 60–64.
  94. Choia, H.; Kim, T.; Kim, S.-H.; Kim, J. Anti-allergic inflammatory triterpenoids isolated from the spikes of Prunella vulgaris. Nat. Prod. Commun. 2016, 11, 2–31.
  95. Khazdair, M.R.; Ghorani, V.; Alavinezhad, A.; Boskabady, M.H. Pharmacological effects of Zataria multiflora Boiss L. and its constituents focus on their anti-inflammatory, antioxidant, and immunomodulatory effects. Fundam. Clin. Pharmacol. 2018, 32, 26–50.
  96. Milijasevic, B.; Steinbach, M.; Mikov, M.; Raskovic, A.; Capo, I.; Zivkovic, J.; Borisev, I.; Canji, J.; Teofilovic, B.; Vujcic, M.; et al. Impact of winter savory extract (Satureja montana L.) on biochemical parameters in serum and oxidative status of liver with application of the principal component analysis in extraction solvent selection. Eur. Rev. Med. Pharmacol. Sci. 2022, 26, 4721–4734.
  97. Shin, T.Y.; Kim, S.H.; Suk, K.; Ha, J.H.; Kim, I.K.; Lee, M.G.; Jun, C.D.; Kim, S.Y.; Lim, J.P.; Eun, J.S.; et al. Anti-allergic effects of Lycopus lucidus on mast cell-mediated allergy model. Toxicol. Appl. Pharmacol. 2005, 209, 255–262.
  98. Mousavi Nia, A.; Pari Kalantaripour, T.; Basiri, M.; Vafaee, F.; Asadi-Shekaari, M.; Eslami, A.; Darvish Zadeh, F. Nepeta Dschuparensis Bornm extract moderates COX-2 and IL-1β proteins in a rat model of cerebral ischemia. Iran. J. Med. Sci. 2017, 42, 179–186.
  99. Bian, M.; Zhang, Y.; Du, X.; Xu, J.; Cui, J.; Gu, J.; Zhu, W.; Zhang, T.; Chen, Y. Apigenin-7-diglucuronide protects retinas against bright light-induced photoreceptor degeneration through the inhibition of retinal oxidative stress and inflammation. Brain Res. 2017, 1663, 141–150.
  100. García-Díaz, J.A.; Navarrete-Vázquez, G.; García-Jiménez, S.; Hidalgo-Figueroa, S.; Almanza-Pérez, J.C.; Alarcón-Aguilar, F.J.; Gómez-Zamudio, J.; Cruz, M.; Ibarra-Barajas, M.; Estrada-Soto, S. Antidiabetic, antihyperlipidemic and anti-inflammatory effects of tilianin in streptozotocin-nicotinamide diabetic rats. Biomed. Pharmacother. 2016, 83, 667–675.
  101. Shen, W.; Anwaier, G.; Cao, Y.; Lian, G.; Chen, C.; Liu, S.; Tuerdi, N.; Qi, R. Atheroprotective Mechanisms of Tilianin by Inhibiting Inflammation Through Down-Regulating NF-κB Pathway and Foam Cells Formation. Front. Physiol. 2019, 10, 825.
  102. Nie, L.; Li, R.; Huang, J.; Wang, L.; Ma, M.; Huang, C.; Wu, T.; Yan, R.; Hu, X. Abietane diterpenoids from Dracocephalum moldavica L. and their anti-inflammatory activities in vitro. Phytochemistry 2021, 184, 112680.
  103. Chen, S.; Fang, A.; Zhong, Y.; Tang, J. Ziziphora clinopodioides Lam leaf aqueous extract mediated novel green synthesis of iron nanoparticles and its anti-hemolytic anemia potential: A chemobiological study. Arab. J. Chem. 2022, 15, 103561.
  104. Mohammad, G.; Tabrizi, M.; Ardalan, T.; Yadamani, S.; Safavi, E. Green synthesis of zinc oxide nanoparticles and evaluation of anti-angiogenesis, anti-inflammatory and cytotoxicity properties. J. Biosci. 2019, 44, 30.
  105. Singh, M.K.; Gidwani, B.; Gupta, A.; Dhongade, H.; Kaur, C.D.; Kashyap, P.P.; Tripathi, D.K. A review of the medicinal plants of genus Orthosiphon (Lamiaceae). Int. J. Biol. Chem. 2015, 9, 318–331.
  106. Andrade, J.M.; Custódio, L.; Romagnoli, A.; Reis, C.P.; Rodrigues, M.J.; Garcia, C.; Petruccioli, E.; Goletti, D.; Faustino, C.; Fimia, G.M.; et al. Antitubercular and anti-inflammatory properties screening of natural products from Plectranthus species. Future Med. Chem 2018, 10, 1677–1691.
  107. Almeida-Bezerra, J.W.; Rodrigues, F.C.; Lima Bezerra, J.J.; Vieira Pinheiro, A.A.; Almeida De Menezes, S.; Tavares, A.B.; Costa, A.R.; Augusta De Sousa Fernandes, P.; Bezerra Da Silva, V.; Martins Da Costa, J.G.; et al. Traditional Uses, Phytochemistry, and Bioactivities of Mesosphaerum suaveolens (L.) Kuntze. Evid.-Based Complement. Altern. Med. 2022, 10, 3829180.
  108. Leung, C.H.; Grill, S.P.; Lam, W.; Gao, W.; Sun, H.D.; Cheng, Y.C. Eriocalyxin B inhibits nuclear factor-κB activation by interfering with the binding of both p65 and p50 to the response element in a noncompetitive manner. Mol. Pharmacol. 2006, 70, 1946–1955.
  109. Jiang, H.; Li, X.; Sun, H.; Zhang, H.; Puno, P. Scopariusols L-T, nine new ent-kaurane diterpenoids isolated from Isodon scoparius. Chin. J. Nat. Med. 2018, 16, 456–464.
  110. Zhang, Y.Y.; Jiang, H.Y.; Liu, M.; Hu, K.; Wang, W.G.; Du, X.; Li, X.N.; Pu, J.X.; Sun, H.D. Bioactive ent-kaurane diterpenoids from Isodon rubescens. Phytochemistry 2017, 143, 199–207.
  111. Yin, Q.-Q.; Liu, C.-X.; Wu, Y.-L.; Wu, S.-F.; Wang, Y.; Zhang, X.; Hu, X.-J.; Pu, J.-X.; Lu, Y.; Zhou, H.-C.; et al. Preventive and Therapeutic Effects of Adenanthin on Experimental Autoimmune Encephalomyelitis by Inhibiting NF-κB Signaling. J. Immunol. 2013, 191, 2115–2125.
  112. Lu, Y.; Chen, B.; Song, J.H.; Zhen, T.; Wang, B.Y.; Li, X.; Liu, P.; Yang, X.; Zhang, Q.L.; Xi, X.D.; et al. Eriocalyxin B ameliorates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells. Proc. Natl. Acad. Sci. USA 2013, 110, 2258–2263.
  113. Zhang, L.G.; Yu, Z.Q.; Yang, C.; Chen, J.; Zhan, C.S.; Chen, X.G.; Zhang, L.; Hao, Z.Y.; Liang, C.Z. Effect of Eriocalyxin B on prostatic inflammation and pelvic pain in a mouse model of experimental autoimmune prostatitis. Prostate 2020, 80, 1394–1404.
  114. He, H.; Jiang, H.; Chen, Y.; Ye, J.; Wang, A.; Wang, C.; Liu, Q.; Liang, G.; Deng, X.; Jiang, W.; et al. Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity. Nat. Commun. 2018, 9, 2550.
  115. Zhang, Y.; Wang, K.; Chen, H.; He, R.; Cai, R.; Li, J.; Zhou, D.; Liu, W.; Huang, X.; Yang, R.; et al. Anti-inflammatory lignans and phenylethanoid glycosides from the root of Isodon ternifolius (D.Don) Kudô. Phytochemistry 2018, 153, 36–47.
  116. Yan, B.C.; Wang, W.G.; Hu, D.B.; Sun, X.; Kong, L.M.; Li, X.N.; Du, X.; Luo, S.H.; Liu, Y.; Li, Y.; et al. Phomopchalasins A and B, two cytochalasans with polycyclic-fused skeletons from the endophytic fungus Phomopsis sp. Org. Lett. 2016, 18, 1108–1111.
  117. Ĺopez-Garcia, R.E.; Rabanal, R.M.; Darias, V.; Martín-Herrera, D.; Carreiras, M.C.; Rodríguez, B. A preliminary study of Cedronella canariensis (L.) var. canariensis extracts for antiinflammatory and analgesic activity in rats and mice. Phytother. Res. 1991, 5, 273–275.
  118. Olajide, O.A.; Oladiran, O.O.; Awe, S.O.; Makinde, J.M. Pharmacological evaluation of Hoslundia opposita extract in rodents. Phytother. Res. 1998, 12, 364–366.
  119. Aljohani, A.S.M.; Alhumaydhi, F.; Rauf, A.; Hamad, E.; Rashid, U. In Vivo and In Vitro biological evaluation and molecular docking studies of compounds isolated from Micromeria biflora (Buch. Ham. ex D.Don) Benth. Molecules 2022, 27, 3377.
  120. Vladimir-Knežević, S.; Cvijanović, O.; Blažeković, B.; Kindl, M.; Štefan, M.B.; Domitrović, R. Hepatoprotective effects of Micromeria croatica ethanolic extract against CCl4-induced liver injury in mice. BMC Complement. Altern. Med. 2015, 15, 1–12.
  121. Wang, X.; Cheng, K.; Liu, Z.; Sun, Y.; Zhou, L.; Xu, M.; Dai, X.; Xiong, Y.; Zhang, H. Bioactive constituents of Mosla chinensis-cv. Jiangxiangru ameliorate inflammation through MAPK signaling pathways and modify intestinal microbiota in DSS-induced colitis mice. Phytomedicine 2021, 93, 153804.
  122. Álvarez-Santos, N.; Estrella-Parra, E.A.; Benítez-Flores, J.d.C.; Serrano-Parrales, R.; Villamar-Duque, T.E.; Santiago-Santiago, M.A.; González-Valle, M.D.R.; Avila-Acevedo, J.G.; García-Bores, A.M. Asterohyptis stellulata: Phytochemistry and wound healing activity. Food Biosci. 2022, 50, 102150.
  123. Chen, J.; Wang, J.B.; Yu, C.H.; Chen, L.Q.; Xu, P.; Yu, W.Y. Total flavonoids of Mosla scabra leaves attenuates lipopolysaccharide-induced acute lung injury via down-regulation of inflammatory signaling in mice. J. Ethnopharmacol. 2013, 148, 835–841.
  124. Becker, K.; Schwaiger, S.; Waltenberger, B.; Fuchs, D.; Pezzei, C.K.; Schennach, H.; Stuppner, H.; Gostner, J.M. Immunomodulatory effects of diterpene quinone derivatives from the roots of Horminum pyrenaicum in human PBMC. Oxid. Med. Cell. Longev. 2018, 2018, 2980295.
  125. Moreno-Pérez, G.F.; González-Trujano, M.E.; Hernandez-Leon, A.; Valle-Dorado, M.G.; Valdés-Cruz, A.; Alvarado-Vásquez, N.; Aguirre-Hernández, E.; Salgado-Ceballos, H.; Pellicer, F. Antihyperalgesic and Antiallodynic Effects of Amarisolide A and Salvia amarissima Ortega in Experimental Fibromyalgia-Type Pain. Metabolites 2023, 13, 59.
  126. Chen, H.; Li, Y.; Wang, J.; Zheng, T.; Wu, C.; Cui, M.; Feng, Y.; Ye, H.; Dong, Z.; Dang, Y. Plant Polyphenols Attenuate DSS-induced Ulcerative Colitis in Mice via Antioxidation, Anti-inflammation and Microbiota Regulation. Int. J. Mol. Sci. 2023, 24, 10828.
  127. Li, Z.; Zhang, Y.; Zhou, Y.; Wang, F.; Yin, C.; Ding, L.; Zhang, S. Tanshinone IIA suppresses the progression of lung adenocarcinoma through regulating CCNA2-CDK2 complex and AURKA/PLK1 pathway. Sci. Rep. 2021, 11, 23681.
  128. Zhang, Q.W.; Lin, L.G.; Ye, W.C. Techniques for extraction and isolation of natural products: A comprehensive review. Chin. Med. 2018, 13, 20.
  129. Albano, S.M.; Miguel, M.G. Biological activities of extracts of plants grown in Portugal. Ind. Crops Prod. 2011, 33, 338–343.
  130. Abbasloo, E.; Dehghan, F.; Khaksari, M.; Najafipour, H.; Vahidi, R.; Dabiri, S.; Sepehri, G.; Asadikaram, G. The anti-inflammatory properties of Satureja khuzistanica Jamzad essential oil attenuate the effects of traumatic brain injuries in rats. Sci. Rep. 2016, 6, 31866.
  131. Salehi, B.; Mishra, A.P.; Shukla, I.; Sharifi-Rad, M.; Contreras, M.d.M.; Segura-Carretero, A.; Fathi, H.; Nasrabadi, N.N.; Kobarfard, F.; Sharifi-Rad, J. Thymol, thyme, and other plant sources: Health and potential uses. Phytother. Res. 2018, 32, 1688–1706.
  132. Mahomoodally, M.F.; Devi Dursun, P.; Venugopala, K.N. Collinsonia canadensis L. In Naturally Occurring Chemicals against Alzheimer’s Disease; Elsevier: Amsterdam, The Netherlands, 2021; pp. 373–377.
  133. Aminian, A.R.; Mohebbati, R.; Boskabady, M.H. The Effect of Ocimum basilicum L. and its main ingredients on respiratory disorders: An experimental, preclinical, and clinical review. Front. Pharmacol 2022, 12, 805391.
  134. Pandur, E.; Micalizzi, G.; Mondello, L.; Horváth, A.; Sipos, K.; Horváth, G. Antioxidant and anti-Inflammatory effects of Thyme (Thymus vulgaris L.) essential oils prepared at different plant phenophases on Pseudomonas aeruginosa LPS-Activated THP-1 macrophages. Antioxidants 2022, 11, 1330.
  135. Bounihi, A.; Hajjaj, G.; Alnamer, R.; Cherrah, Y.; Zellou, A. In vivo potential anti-inflammatory activity of Melissa officinalis l. essential oil. Adv. Pharmacol. Sci. 2013, 2013, 101759.
  136. Sun, Z.; Wang, H.; Wang, J.; Zhou, L.; Yang, P. Chemical composition and anti-inflammatory, cytotoxic and antioxidant activities of essential oil from leaves of Mentha piperita grown in China. PLoS ONE 2014, 9, e114767.
  137. Pandur, E.; Balatinácz, A.; Micalizzi, G.; Mondello, L.; Horváth, A.; Sipos, K.; Horváth, G. Anti-inflammatory effect of lavender (Lavandula angustifolia Mill.) essential oil prepared during different plant phenophases on THP-1 macrophages. BMC Complement. Med. 2021, 21, 287.
  138. Kim, K.M.; Kim, S.Y.; Mony, T.J.; Bae, H.J.; Han, S.D.; Lee, E.S.; Choi, S.H.; Hong, S.H.; Lee, S.D.; Park, S.J. Dracocephalum moldavica ethanol extract suppresses LPS-induced inflammatory responses through inhibition of the JNK/ERK/NF-κB signaling pathway and IL-6 production in raw 264.7 macrophages and in endotoxic-treated mice. Nutrients 2021, 13, 12.
  139. Wang, Y.Y.; Lin, S.Y.; Chen, W.Y.; Liao, S.L.; Wu, C.C.; Pan, P.H.; Chou, S.T.; Chen, C.J. Glechoma hederacea extracts attenuate cholestatic liver injury in a bile duct-ligated rat model. J. Ethnopharmacol. 2017, 204, 58–66.
  140. Tubon, I.; Bernardini, C.; Antognoni, F.; Mandrioli, R.; Potente, G.; Bertocchi, M.; Vaca, G.; Zannoni, A.; Salaroli, R.; Forni, M. Clinopodium tomentosum (Kunth) govaerts leaf extract influences in vitro cell proliferation and angiogenesis on primary cultures of porcine aortic endothelial cells. Oxid. Med. Cell. Longev. 2020, 2020, 298461.
  141. Sheychenko, O.P.; Sheychenko, V.I.; Goryainov, S.V.; Zvezdina, E.V.; Kurmanova, E.N.; Ferubko, E.V.; Uyutova, E.V.; Potanina, O.G.; Fadi, K. Chemical composition and biological activity of the dry extract “Rosmatin” from the herb of Dracocephalum moldavica L. Khimiya Rastitel’nogo Syr’ya 2021, 3, 253–264.
  142. Zotsenko, L.; Kyslychenko, V.; Kalko, K.; Drogovoz, S. The study of phenolic composition and acute toxicity, anti-inflammatory and analgesic effects of dry extracts of some Elsholtzia genus (Lamiaceae) species. Archives 2021, 2, 637–649.
  143. Mićović, T.; Katanić Stanković, J.S.; Bauer, R.; Nöst, X.; Marković, Z.; Milenković, D.; Jakovljević, V.; Tomović, M.; Bradić, J.; Stešević, D.; et al. In vitro, in vivo and in silico evaluation of the anti-inflammatory potential of Hyssopus officinalis L. subsp. aristatus (Godr.) Nyman (Lamiaceae). J. Ethnopharmacol. 2022, 293, 115201.
  144. Deng, Y.; Hua, J.; Wang, W.; Zhan, Z.; Wang, A.; Luo, S. Cytotoxic terpenoids from the roots of Dracocephalum taliense. Molecules 2018, 23, 57.
  145. Jia, T.; Cai, M.; Ma, X.; Li, M.; Qiao, J.; Chen, T. Oridonin inhibits IL-1β-induced inflammation in human osteoarthritis chondrocytes by activating PPAR-γ. Int. Immunopharmacol. 2019, 69, 382–388.
More
This entry is offline, you can click here to edit this entry!
ScholarVision Creations